Fundz

Resolution Therapeutics Appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer

PRIVATESep 10, 2025

Position

Chief Business Officer

Company

Resolution Therapeutics

Daniel Kennedy
daniel.kennedy@resolution-tx.com
EdinburghBiotechnologyresearch

Description

Resolution Therapeutics has announced the appointment of Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer. Their expertise is expected to strengthen the company's leadership team at a pivotal moment in its development.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Resolution Therapeutics, and when

A new leader at Resolution Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Resolution Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Resolution Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Resolution Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Resolution Therapeutics

Location

Little France Drive

Edinburgh, Scotland, United Kingdom

About

Resolution Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering regenerative macrophage therapy in inflammatory and fibrotic diseases. The Company leverages its proprietary platform to develop macrophages with pro-regenerative properties for superior patient outcomes. Resolution's initial focus is on developing RTX001, its lead product with first-in-class potential supported by preclinical data demonstrating anti-fibrotic and anti-inflammatory advantages relative to non-engineered macrophages, to treat patients with end-stage liver disease. The Company is also advancing efforts to expand the potential of its platform into inflammatory and fibrotic indications beyond liver disease, including graft-vs-host disease (GVHD) and lung fibrosis. Resolution, a spinout from Professor Stuart Forbes's lab at the University of Edinburgh, is based in Edinburgh and London.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Resolution Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Steven
Likely contact at this company
••••••••@••••••••

See Steven's verified email →

Amir
Likely contact at this company
••••••••@••••••••

See Amir's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Resolution Therapeutics's next move

Learn about Strategic plan

Resolution Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.